What is the best treatment for primary breast lymphoma? Combined modality should be adapted according to the risk stratification.
Park
Yeon Hee
YH
Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yhparkhmo@smc.samsung.co.kr
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000628:therapy*; D012008:Recurrence; D012306:Risk; D016896:Treatment Outcome
D000970:Antineoplastic Agents